Neutrogena Says It Made Hayden Panettiere Feel Unsupported
Neutrogena Says It Made Hayden Panettiere Feel Unsupported
Neutrogena has acknowledged it made Hayden Panettiere feel unsupported after she spoke about postpartum depression. The statement came days after her death at 36 and after weeks of public anger over what she said happened in 2015.
Panettiere told interviewers this spring that the brand tried to end her contract after she discussed her mental health on daytime television. She said a morality clause was cited. She said she was shocked. In a May podcast interview, she put it plainly: “Neutrogena attempted to terminate me as a spokesperson after I discussed my postpartum depression.”
That account sat in the background for months. It moved to the front after she died on August 16 in South Carolina. Authorities have said there were no signs of foul play. The official cause of death has not been released. What followed was a wave of questions about what her story meant for other women, and what a company owes a person who has carried its name for a decade.
Neutrogena posted a statement on social media on August 20. It said the company was deeply saddened by her passing. It called her a valued member of the Neutrogena community. It said, “We are proud to have partnered with her and understand that we made her feel unsupported during a very difficult time.” The statement added, “This is not what Neutrogena stands for or who we want to be.”
The brand also said it would make a significant investment to a community health partner to help more women access support, including care for postpartum depression. It did not share a dollar figure or a timeline. It did not respond to requests for an interview, according to reporting by The New York Times.
I read that line about feeling unsupported and I paused. It is a plain sentence. It does not argue. It does not explain the contract. It names a feeling and accepts it. That matters. But it also arrives after a death, and after a long silence. That timing changes how it lands.
Panettiere’s story was not secret. She wrote about it in her 2026 memoir, This Is Me: A Reckoning. She spoke about it on book tour. She described a ten-year partnership that began when she was a teenager and ended in 2015 or 2016, depending on the account. She said her agent told the company that ending the deal for that reason would be illegal. She said the contract ran out that year and was not renewed. She said there was no goodbye.
Morality clauses are common in endorsement deals. They allow a company to end a relationship if a person’s conduct or public image risks reputational harm. Legal experts have noted that these clauses were written for a different era. They often do not reflect today’s understanding of mental health as a medical condition, not a moral failing. Panettiere made that point herself. She said postpartum depression was her truth, and it was not something to be punished.
The public response has been sharp. Calls for a boycott spread on social media. Some people said they would stop buying Neutrogena products. Others said the brand’s silence since May had been its own message. When a company does not speak, people fill the gap. They assume the worst. That is what happened here.
I worry about what this means for the next woman who wants to speak. She may be under contract. She may be told to stay quiet. She may fear losing income. She may fear being labeled difficult. That fear is real. It is not abstract. It shapes choices in rooms where no one is keeping minutes.
Neutrogena’s promise to invest in maternal mental health is a start. It is not an answer. Money can help fund care. It can expand access. It cannot rewrite a contract after the fact. It cannot change the way a person felt when she was told she was a problem. That part is done. What remains is whether the company will do more than post a statement.
There are still unknowns. The exact terms of the contract have not been made public. The company has not confirmed Panettiere’s account in detail. It has acknowledged her feeling of being unsupported. It has not said whether a morality clause was invoked. It has not said who made the decision or why. Those gaps matter. They keep the story from being fully clear.
What I keep returning to is the ordinary person in this. Not the analyst. Not the lawyer. The mother who reads this while feeding a baby at 3 a.m. The woman who wonders if speaking up will cost her something she cannot afford to lose. The friend who wants to help but does not know what to say. This story is for them. It is about what happens when a brand meets a human struggle and chooses silence.
Neutrogena has broken that silence now. It has said it made a mistake. It has said it will invest. The next step is action that can be seen and measured. A program with a name. A hotline that works. A partnership that lasts. Without that, the statement is just words on a screen.
I do not know if this will change how contracts are written. I do not know if other companies will follow. I do know that Panettiere’s voice is gone. What remains is whether her story leads to something real for women who are still here, still struggling, and still deciding whether to speak.